Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy

Metronomic therapy has been gaining importance in the neoadjuvant setting of breast cancer treatment. Its clinical benefits may involve antiangiogenic machinery. Cancer cells induce angiogenesis to support tumor growth by secreting factors, such as vascular endothelial growth factor (VEGF). In breas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomark Res
Autors principals: Arai, Roberto J., Petry, Vanessa, Hoff, Paulo M., Mano, Max S.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001168/
https://ncbi.nlm.nih.gov/pubmed/29946467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0135-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars